Personalised ILM peeling for Myopic traction maculopathy.

IF 4.4 3区医学 Q1 OPHTHALMOLOGY

Eye Pub Date : 2026-10-15 DOI:10.1038/s41433-026-04934-y

Kengo Uramoto, Tomonari Takahashi, Keigo Sugisawa, Hiroyuki Takahashi, Koju Kamoi, Kyoko Ohno-Matsui

{"title":"Personalised ILM peeling for Myopic traction maculopathy.","authors":"Kengo Uramoto, Tomonari Takahashi, Keigo Sugisawa, Hiroyuki Takahashi, Koju Kamoi, Kyoko Ohno-Matsui","doi":"10.1038/s41433-026-04934-y","DOIUrl":null,"url":null,"abstract":"Purpose: To introduce a novel ILM peeling technique for S2 and S3 retinoschisis, termed 'Personalised ILM peeling', which selectively peels the ILM only within the schisis area while minimising postoperative complications.Methods: 10 eyes from 9 patients with MRS underwent 'Personalised ILM peeling'. Preoperatively, the OCT radial scans, 3D Wide scans and retinal thickness map were comprehensively evaluated to delineate the extent of the schisis area and determine the specific region requiring ILM peel. Pre- and postoperative visual acuity, retinal thickness, including retinoschisis height, and visual field were analyzed.Results: No case of recurrence were observed during a follow-up period exceeding 24 months. No Postoperative complications occurred in any of the 10 cases. Compared with preoperative measurements, postoperative visual acuity and retinal thickness, including retinoschisis height, demonstrated significant improvement.Conclusions: Personalised ILM peeling is proposed as a novel, minimally invasive surgical approach for MRS. Many cases with high myopia are accompanied by visual field defects and it is expected that this will avoid damage to the fragile retina and nerve fibres.","PeriodicalId":12125,"journal":{"name":"Eye","volume":" ","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41433-026-04934-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To introduce a novel ILM peeling technique for S2 and S3 retinoschisis, termed 'Personalised ILM peeling', which selectively peels the ILM only within the schisis area while minimising postoperative complications.

Methods: 10 eyes from 9 patients with MRS underwent 'Personalised ILM peeling'. Preoperatively, the OCT radial scans, 3D Wide scans and retinal thickness map were comprehensively evaluated to delineate the extent of the schisis area and determine the specific region requiring ILM peel. Pre- and postoperative visual acuity, retinal thickness, including retinoschisis height, and visual field were analyzed.

Results: No case of recurrence were observed during a follow-up period exceeding 24 months. No Postoperative complications occurred in any of the 10 cases. Compared with preoperative measurements, postoperative visual acuity and retinal thickness, including retinoschisis height, demonstrated significant improvement.

Conclusions: Personalised ILM peeling is proposed as a novel, minimally invasive surgical approach for MRS. Many cases with high myopia are accompanied by visual field defects and it is expected that this will avoid damage to the fragile retina and nerve fibres.

查看原文本刊更多论文

个体化ILM脱皮治疗近视牵引性黄斑病变。

目的：介绍一种用于S2和S3视网膜裂的新型ILM剥离技术，称为“个性化ILM剥离”，该技术可选择性地仅在裂片区域内剥离ILM，同时将术后并发症降至最低。方法：对9例MRS患者的10只眼进行“个体化眼内膜剥离”。术前综合评估OCT径向扫描、3D宽扫描和视网膜厚度图，描绘裂裂区域的范围，确定需要ILM剥离的特定区域。分析术前和术后视力、视网膜厚度（包括视网膜裂高度）和视野。结果：随访24个月，无复发病例。10例均无术后并发症发生。与术前相比，术后视力和视网膜厚度（包括视网膜裂高度）均有显著改善。结论：个体化眼内膜剥离是治疗mrs的一种新颖的微创手术方法，许多高度近视患者伴有视野缺损，这将避免对脆弱的视网膜和神经纤维的损伤。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Eye 医学-眼科学

CiteScore

6.40

自引率

5.10%

发文量

481

审稿时长

3-6 weeks

期刊介绍： Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists. Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease; oculo-plastic surgery; orbital and lacrimal disease; ocular surface and corneal disorders; paediatric ophthalmology and strabismus; glaucoma; medical and surgical retina; neuro-ophthalmology; cataract and refractive surgery; ocular oncology; ophthalmic pathology; ophthalmic genetics.